Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cogent

18.50
+0.95005.41%
Post-market: 18.750.2500+1.35%17:47 EST
Volume:2.38M
Turnover:43.66M
Market Cap:908.74M
PE:-4.55
High:18.98
Open:17.49
Low:17.32
Close:17.55
52wk High:85.18
52wk Low:15.96
Shares:49.12M
Float Shares:47.97M
Volume Ratio:0.80
T/O Rate:4.96%
Dividend:4.02
Dividend Rate:21.75%
EPS(TTM):-4.0643
EPS(LYR):-4.2848
ROE:-136.94%
ROA:-2.47%
PB:-23.20
PE(LYR):-4.32

Loading ...

Cogent Biosciences: Hold Rating Amid Anticipated Positive Data and Pipeline Developments

TIPRANKS
·
Nov 04

Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2025 Financial Results

GlobeNewswire
·
Nov 03

Cogent Biosciences Announces Multiple Presentations at the 67th Annual American Society of Hematology (ASH) Meeting

GlobeNewswire
·
Nov 03

Did Temporary Revenue Recognition Lag Just Shift Cogent Communications Holdings' (CCOI) Long-Term Growth Narrative?

Simply Wall St.
·
Oct 30

Cogent Biosciences’ Phase 2 Study on Bezuclastinib: A Potential Game-Changer for Advanced Systemic Mastocytosis

TIPRANKS
·
Oct 28

Cogent Biosciences Announces KRAS Poster Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GlobeNewswire
·
Oct 25

Cogent Communications Holdings Inc. to Release Third Quarter 2025 Results

Reuters
·
Oct 21

Cogent Biosciences Is Maintained at Overweight by JP Morgan

Dow Jones
·
Oct 21

Promising Outlook for Cogent Biosciences: Buy Rating Backed by FDA Breakthrough Designation and Strong Phase 3 Trial Prospects

TIPRANKS
·
Oct 20

Cogent Biosciences announces FDA BTD for bezuclastinib

TIPRANKS
·
Oct 20

Cogent Biosciences Announces FDA Breakthrough Therapy Designation for Bezuclastinib

GlobeNewswire
·
Oct 20

Cogent Biosciences Initiated at Hold by Stifel

Dow Jones
·
Oct 16

Stifel Nicolaus Initiates Coverage on Cogent Biosciences With Hold Rating, $16 Price Target

MT Newswires Live
·
Oct 16

Cogent Biosciences initiated with a Hold at Stifel

TIPRANKS
·
Oct 16

Cogent Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 30

Cogent Communications Holdings Up Over 8%, on Pace for Largest Percent Increase Since July 2024 -- Data Talk

Dow Jones
·
Sep 23

Cogent Biosciences Signs Lease for New Headquarters

TIPRANKS
·
Sep 12

Fed Should Admit Its 'Mistakes,' Jefferies Analyst Says, Making A 'Cogent' Case For 75 Bps Rate Cut

Benzinga_recent_news
·
Sep 11

VP of Network Strategy Henry W. Kilmer Reports Disposal of Cogent Communications Holdings Inc. Common Shares

Reuters
·
Sep 06

Cogent Communications Files Initial Ownership Statement for Mark Andrew Harris, VP & Chief Revenue Officer

Reuters
·
Sep 03